Salesforce stock price target maintained at $240 by TD Cowen

TD Cowen reiterated a Buy rating on Salesforce with a $240 price target, while the stock trades around $191 and InvestingPro flags it as below Fair Value. The note highlights accelerating Agentic Work Unit consumption, up 111% quarter over quarter in Q1 versus 57%, 62%, 34% and 21% in the prior four quarters, supporting the company’s AI monetization thesis. Salesforce also reported $42.83 billion in trailing revenue, 77.6% gross margin, and a quarterly dividend of $0.44 per share payable July 2, 2026.

Analysis

The setup is less about headline AI enthusiasm and more about a potential re-rating of CRM’s revenue mix. If agentic workloads truly shift from pilot usage to recurring enterprise consumption, the market should start valuing Salesforce more like a usage-accelerating infrastructure layer than a mature software vendor, which would expand multiples even before the monetization model is fully visible. The key second-order effect is that Slack becomes strategic not as a messaging asset, but as the control plane that reduces switching costs and increases workflow stickiness across third-party tools.

The main near-term risk is that consumption growth can stay strong while revenue lag remains noisy, creating a “good metrics / bad skepticism” regime for several quarters. That matters because the stock can de-rate if investors conclude the AI layer is driving activity but not ARPU, especially with a large installed base already optimized for margin. Conversely, if agent adoption continues to propagate through enterprise orgs, the next catalyst is not another earnings beat but commentary showing the attach rate broadening from early adopters into core workflow budgets over the next 2-3 quarters.

What the market may be missing is that the upside case is less linear than the current consensus implies: AI agents can increase platform usage without immediately improving top-line visibility, but once embedded, they can also compress churn and lift expansion rates faster than expected. That creates asymmetric optionality in the medium term, while the short term remains vulnerable to any disappointment in monetization language or guidance discipline. The implied message: the stock can work even if the AI revenue story is still embryonic, but only if investors keep paying for future monetization rather than current proof.

Key Decisions for Investors

• Go long CRM on any post-earnings or post-rally consolidation over the next 2-6 weeks; target a re-test of the sell-side consensus range if agentic consumption remains >100% QoQ, with downside limited to a reset toward prior resistance if monetization commentary stalls.
• Buy CRM Jan-2027 calls / call spreads to express the multi-quarter monetization optionality; risk/reward is favorable because the thesis depends on adoption compounding, not immediate margin lift.
• Pair trade: long CRM vs short a basket of slower-growth large-cap software names with less workflow lock-in, to isolate the market’s willingness to pay for AI platform optionality rather than generic SaaS duration.
• If CRM gaps sharply higher on headline AI enthusiasm, use strength to trim 25-35% and keep only the long-dated optionality; the principal risk is narrative exhaustion before revenue proof arrives.